Outsourcing Survey

2013 Annual Outsourcing Survey

Welcome to our 9th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Here’s a breakdown of the respondents, by company type and job function:

Company Type
  • Small/Mid-Tier Pharma: 20.1%
  • Top 20 Pharma: 19.0%
  • Generic Pharma: 12.3%
  • Specialty Pharma: 12.3%
  • Emerging Biopharma: 8.4%
  • Virtual Pharma: 6.5%
  • Consumer/OTC: 5.2%
  • Top 10 Biopharma: 3.9%
  • Other: 12.3%

Job Function
  • Corporate Management: 21.4%
  • R&D: 20.4%
  • Project Manager: 8.4%
  • Purchasing/Sourcing: 8.4%
  • Production/Manufacturing/Packaging: 7.8%
  • QA/QC/Validation: 6.5%
  • Business Development: 5.2%
  • Contract Manager: 5.2%
  • Marketing/Sales: 4.5%
  • Clinical Research: 3.2%
  • Supply Chain Manager: 2.6%
  • Regulatory Affairs: 1.9%
  • Engineering: 1.3%
  • Other: 3.2%

Peaking?

Last year, 48% of respondents believed that they will spend the same or less on outsourcing spending in the coming year; this year, that climbed to 53%. Meanwhile, 49%, told us that they spent the same or less on outsourcing in the previous year, the same as in our 2012 survey. 18% of respondents said that 2012 saw no change in outsourcing spending from 2011.

28% of respondents tell us they had cancelled outsourcing projects in the previous year due to the economy; up from 23% in our 2012 survey. Small/Mid-Tier Pharma respondents had the highest “cancellation rate” of any company type, at 59% (!).

50% of respondents said that more than half of their outsourcing dollars go to preferred providers. 74% of Corporate Management respondents said the same but most other job categories cited lower figures (43% of R&D staff, and 20% QA/QC/Validation staff cited that large a figure).

46% of the respondents said that their companies outsource generic manufacturing, but only 52% of that group said they they have ascertained that their dosage form manufacturers and API suppliers have registered with FDA under GDUFA.

Download the 52-page survey today to find out about the latest pharma & biopharma outsourcing trends!
 
 
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters